Combined PD-1, BRAF and MEK inhibition in advanced BRAF-mutant melanoma: safety run-in and biomarker cohorts of COMBI-i

Reinhard Dummer, Célèste Lebbé, Victoria Atkinson, Mario Mandalà, Paul Nathan, Ana Arance, Erika Richtig, Naoya Yamazaki, Caroline Robert, Dirk Schadendorf, Hussein A. Tawbi, Paolo A. Ascierto, Antoni Ribas, Keith T. Flaherty, Neha Pakhle, Catarina D. Campbell, Daniel Gusenleitner, Aisha Masood, Jan C. Brase, Eduard Gasal, Georgina V. Long